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ABSTRACT
Characterization of Perillyl 
Alcohol as a Cell Migration 
Inhibiting Compound
by
Johanna Wagner
Dr. George Plopper, Examination Committee Chair 
Assistant Professor of Biological Sciences 
University of Nevada, Las Vegas
Inhibiting cancer cell migration could greatly improve the prognosis of 
cancer patients. Prior to commercialization of the Plopper laboratory designed a 
96-well plate, we optimized our in vitro migration and cell viability assays to meet 
the standards set by the National Cancer institute for use in a large-scale drug 
screen for anti-migration compounds. Using these assays, we measured the 
cytotoxicity and migration-inhibiting effect of dimethyl sulfuoxide, a drug solvent, 
in three cancer and one non-cancer cell lines. Next, we investigated plant- 
derived compounds called monoterpenes, known chemopreventive/ 
chemotherapeutic agents, for non-cytotoxic, migration-inhibiting properties in 
MCF-10A normal and MDA-MB 435 cancerous breast cells. Perillyl alcohol at
0.5 mM inhibited normal breast cell migration while it failed to affect cancer cell 
migration. Finally, we examined the los.ç of prénylation of RhoA, a
iii
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small GTPase protein Involved in the formation of focal adhesions and stress 
fibers, and corresponding morphological changes following exposure to perillyl 
alcohol.
IV
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CHAPTER 1
GENERAL INTRODUCTION 
Cancer
Cancer progresses in two general stages. Initially, cells fail to respond to 
controls of cell division and multiply excessively, an abnormal mass of 
proliferating cells results called a neoplasm. Neoplasms are classified as benign 
or malignant. A benign neoplasm or tumor is often encapsulated, grows 
relatively slowly and remains confined to the tissue of origin for several years. In 
contrast, malignant neoplasms are nonencapsulated, grow rapidly and acquire 
the ability to invade their surrounding tissues. Malignancy, the second stage of 
cancer, begins with the cells penetrating the surrounding extracellular matrix 
(ECM).
The extracellular matrix has two main components-basement membranes 
and interstitial connective tissue. Basement membranes are continuous 
extracellular structures, which separate organ parenchyma from the underlying 
interstitial connective tissue. These membranes are the first extracellular barrier 
to be crossed by invading tumor cells and consist of a number of proteins and 
glycoproteins which form a highly cross-linked structure (1 ). The major 
constituents of the basement membrane are the protein type IV collagen, laminin 
and nrotfiog!yçan-s. The interstitial connective tissue is «f r«!!e
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distributed in a meshwork of collagen fibers, glycoproteins (e.g. fibronectin). 
proteoglycans and hyaluronic acid.
Metastasis requires cancer cells to pass through basement membranes 
and Interstitial connective tissue at least three times. They initially invade the 
basement membranes during escape from their primary site. Later cancer cells 
cross basement membranes during both entry into and exit from the blood and/or 
lymphatic vessels, ultimately disseminating and proliferating into secondary 
tumors called métastasés.
The development of secondary tumors is a sequential process, commonly 
referred to as a "cascade", and failure to complete any one step prevents 
metastasis (2). For malignant cells to initiate the metastatic cascade they must 
detach themselves from neighboring cells and adhere to the ECM, degrade the 
ECM and migrate through the modified ECM (3). Invading cancer cells must 
therefore be able to bind to the ECM, to release proteolytic enzymes to catalyze 
degradation of the ECM and to produce factors to stimulate their migration 
through the modified extracellular matrix. Many of these chemotactic (motility 
toward a chemical gradient) factors are degradation products of the ECM 
components such as fragments derived from laminin, fibronectin and collagen 
(4). Inhibition of any of these steps could prevent, or at least minimize, the 
spread of cancer.
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Cancer Treatments 
Tumor metastasis is the most deadly aspect of the disease. Unlike 
primary tumors that can be surgically removed and treated with adjuvant 
chemotherapy and/or radiotherapy, métastasés, on the other hand, are difficult to 
treat and usually fatal (2). The majority of anti-cancer drugs developed target the 
hyperproliferation of metastatic cells. While many of these drugs are efficacious 
in treating the beginning stages of cancer, none are curative treatments for 
metastatic disease. A delay in diagnosis is another contributing factor that 
renders many drugs ineffective (5). In addition, antiproliferation compounds 
cause many adverse side effects: nausea, vomiting, suppressed immune system 
and hair loss. Cancer remains the second leading cause of death in the US (6).
It is, therefore, paramount that alternative therapies be developed that treat a 
greater scope of the disease and with less toxicity to the patient.
Inhibiting invasion and metastasis of cancer cells involves many potential 
targets for intervention. Tumor cell motility is a salient characteristic contributing 
to disease progression, but it remains poorly understood. Alterations in the 
expression of growth factor receptors (7-8), changes in the extracellular matrix 
and cell interactions (9) and signal transduction pathways (10) are likely to be 
important. By piecing these factors together in cancer cell migration 
opportunities for new therapeutic treatments should flourish.
Even though tumor cell migration is a hallmark of metastasis, research 
since 1978 has yielded fewer than 100 compounds that have some capacity to 
inhibit tumor cell migration; however, thousands of compounds have yet to be
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tested. The reason for the limited number of identified inhibitors of tumor cell 
migration may be due to the technology used to detect them.
Accurately and rapidly measuring cell migration has been a problem. The 
majority of in vitro cell motility studies are conducted by using modified Boyden 
chambers in which cells are placed in the upper chamber and stimulated to move 
across the extracellular-matrix-protein coated filter by haptotaxis (motility toward 
a bound substrate) (Fig. 1.1); however, the methods by which migration is 
quantified is more diverse. Fixing, staining and manually counting the migrated 
cells under a light microscope is a common, time-consuming method (11-14). 
Binding migrated cells with a fluorescent tag, such as calcein-AM, and then 
quantifying fluorescence with an inverted microscope and computer program is 
another method (15-17). The migrated cells can also be removed with trypsin 
and counted in a Neubauer chamber (18-19). Time-lapsed videomicroscopy is an 
alternative technique for conducting cell motility assays. Cells are viewed with an 
inverted microscope, and a high-resolution black and white video camera and 
recorder record movement (20-21 ). These existing technologies for measuring 
cell migration are flawed because they require too much time and money to 
efficiently screen compounds. One transwell plate, a modified Boyden chamber, 
can hold 12 samples and costs $25. For example, screening 100 compounds 
using transwell plates would require several plates per compound with each 
insert handled separately. Time-lapsed videomicroscopy is also inadequate as it 
provides a detailed examination of individual cells, but is not an appropriate 
technology for screening large numbers of compounds.
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Our lab has developed an economical, accurate, high-throughput method 
for measuring in vitro cell migration. Our newly designed 96-well migration plate 
eliminates the handling of individual filters, reduces the number of cells and 
volume of drug sample used, and allows for many more replicates per treatment 
condition (Fig. 1.2). The addition of an opaque filter on our plate, in conjunction 
with innocuous fluorescent cell labeling, provides the ability to quantify the 
number of migrated at any time point over the 18-hour migration assay (Fig. 1.3). 
Measuring cell viability with assays such as the MTT test is also possible with our 
migration plate. Overall, through the application of new technology we should be 
able to expeditiously identify non-cytotoxic, migration-inhibiting compounds (22).
General Mechanisms of Cell Migration 
Cell locomotion is only partly understood. Gaining insight into how cell 
migration occurs is important for development of anti-migration drugs. Cell 
migration is regulated by a combination of different processes: forces generated 
by contraction of actin and myosin, G protein signaling, microtubule dynamics 
and the turnover of focal adhesions (23). It begins by extending the plasma 
membrane at the front of the cell into what is called lamellipodia. Polymerization 
of the actin cytoskeleton drives the extension of the lamellipodia, and it is 
stabilized by the formation of focal complexes (24). Integrin receptors, actin 
filaments and associated proteins are found grouped together in these focal 
complexes. As the cell advances forward, focal complex binding strength and 
organization increase (24), giving rise to focal adhesions (Fig. 1.4). Focal
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adhesions link the cytoskeleton with the extracellular matrix through 
transmembrane integrin receptors. Through increased strength and 
organization, focal adhesions provide the cell with points of traction over which it 
can move. Release of the rear adhesions permits the entire cell to advance 
fonvard. Therefore, interfering with the turnover of focal adhesion and focal 
complexes could impede cell migration. However, the mechanisms that regulate 
the formation of focal complexes at the cell's leading edge and the release of 
focal adhesions at the cell’s rear remain unclear (23).
Integrin proteins play a key role in the turnover of focal adhesion 
complexes (24). Integrins are heterodimeric proteins consisting of two 
transmembrane glycoprotein subunits (a and (3) that are noncovalently bound to 
each other. For adhesion to ligands, the extracellular domain of both Integrin 
subunits Is needed, as Is the presence of cations. The cytoplasmic domain of 
Integrin a and p subunits anchors the cytoskeleton to the plasma membrane and 
Is required to mediate signaling events. Thus far, the Integrin family Is composed 
of 16 a and 8 3 subunits that form a combination of a P cell surface receptors 
with the ability to mediate bidirectional transmembrane signaling from Inside to 
outside and from outside to Inside the cell (24).
Cell migration Is just one type of cell behavior affected by the activation of 
these cascades. It Is Inslde-out signaling that regulates Integrin affinity for a 
ligand through the propagation of conformational changes from the cytoplasmic 
domain to the extracellular binding site (24). This interaction of Increased 
Integrin affinity for extracellular matrix proteins that induces cell surface clustering
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at focal adhesion sites of the plasma membrane is a process driven from within 
the cell (25). These focal adhesion complexes are composed of cytoskeletal 
proteins (actin, talin, vinculin, paxillin and tensin) and signaling molecules [focal 
adhesion kinase (FAK) cadherin-assoclated kinase (CAS) and Src tyrosine 
kinase] (25) (Fig. 1.5). Following inside-out activation, integrin occupation and 
clustering at focal adhesion complexes elicit outside-in signaling from the 
extracellular matrix to the cell cytoplasm that leads to cell migration, proliferation, 
differentiation and survival (25) (Fig. 1.6).
Rho GTPases
To understand how ECM and Integrin associations work to control cell 
behavior. It Is necessary to Identify proteins that are able to coordinate both cell 
shape and Integrin signaling pathways. A good candidate is the Rho family of 
proteins. These small GTPases are able to relay Integrin-derlved signals, as well 
as organize the actin cytoskeleton (26). Rho GTPases act as molecular switches 
that cycle between the active GTP- bound and inactive GDP-bound states. This 
cycling Is controlled by GDP/GTP exchange factors, GTPase-actlvatIng proteins 
and guanine nucleotide dissociation inhibitors (26). It is presumed that 
Interactions with these molecules take place at the plasma membrane through 
geranylgeranylation of the C-terminus on Rho GTPases (27). Protein prénylation 
modifies certain cellular proteins with either a 15-carbon famesyl or a 20-carbon 
geranylgeranyl group generated from the mevalonate pathway.
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Microinjection with activated and dominant negative Rho family members 
leads to a defined hierarchy of GTPase activation: activated Cdc42 activates 
R ad , which then activates RhoA (23, 27). Rac appears to drive the 
development of lamellipodia, whereas Cdc42 stimulates the polymerization of 
actin at the front to the cell to form long, thin extensions called filopodia (23. 27). 
RhoA activation leads to the production of large, highly organized focal 
adhesions and tension (23, 27).
The role of RhoA in stimulating the assembly of stress fibers and focal 
adhesions is better understood than how Rad or Cdc42 Induces focal complex 
assembly (28). Activated RhoA binds to and activates the serlne/threonlne 
kinase Rho-klnase (ROKa), which In turn phosphorylates and Inhibits myosin 
light chain phosphatase (23. 28-30). This Inhibition results In Increased 
phosphorylation of myosin light chain followed by enhanced myosin filament 
assembly and actln-actlvated myosin ATPase activity (28). Overall, through this 
pathway, RhoA activation results In bundling of actin filament Into stress fibers 
and clustering of Integrins Into focal adhesions. This membrane-cytoskeleton 
Interaction has been reported to Increase Invasiveness In tumor cells from liver 
and breast tissues (29.31 ). Additionally, the level of RhoA expression has been 
reported to be several times higher In tumors than In surrounding normal tissue 
(31 ). RhoA Is also Involved In a variety of other biological processes such as 
cytokinesis, smooth muscle contraction, transformation and apoptosis (31).
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GTPases have also been reported to play an important role in the 
metastatic behavior of tumor cells (32). Therefore, blocking the activation of 
these proteins by Inhibiting their Isoprenylation could reduce metastasis (19).
Monoterpenes: Perillyl Alcohol
The monoterpenes limonene and perillyl alcohol (POH) and their 
metabolites have been shown to Inhibit the Isoprenylation of protein In cultured 
3T3 cells as well as other types of cells (33) (Fig. 1.7). These monoterpenes are 
plant-derived. Inexpensive, low In toxicity and currently In Phase II clinical trials 
for use as a chemopreventive/chemotherapeutic agent In liver, colon and 
pancreatic cancer. The cancer suppressing chemopreventive activity of 
monoterpenes during the promotion phase of carcinogenesis act to prevent the 
growth of Initiated cells. In chemopreventlon of mammary and liver 
carcinogenesis monoterpenes may act by Inhibiting tumor cell proliferation or 
accelerating the rate of tumor cell death (34).
Though Its exact mechanism of action Is not known, perillyl alcohol Is 
known to Inhibit prenyl transferases Including geranylgeranyl protein transferase I 
(GGPTase 1 ) (35-36). One target of the enzyme GGPTase 1 Is the small G 
protein RhoA: Addition of a geranylgeranyl group to RhoA allows it to become 
membrane associated upon activation. Activated RhoA In turn stimulates 
chemical signaling pathways that lead to cell migration and suppression of 
apoptosis. However, differences have been observed in the Inhibition of perillyl 
alcohol on the activity of type I and type II geranylgeranyl-protein transferases
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and femesyl-protein transferases in different cell lines (37). Thus, in determining 
the anticancer mechanism of perillyl alcohol, it is Important to evaluate this 
biochemical effect in the particular cell type.
To date there are no published studies examining the effects of perillyl 
alcohol on cell migration, though I have accumulated data demonstrating that 
perillyl alcohol Inhibits migration of the human breast cell line MCF-10A at sub- 
lethal doses. Therefore, the central hypothesis of my thesis Is that perillyl alcohol 
Inhibits migration of these cells by blocking a RhoA-assoclated signaling pathway 
that Includes Rho-klnase (ROKa) and myosin light chain.
In chapter 2 ,1 establish the parameters for Implementing a large-scale 
drug screen of anti-cancer agents to Identify antl-mlgratlon compounds using 
three human cancer cell lines and one human nontumorlgenic breast cell line. 
Next. In chapter 3 ,1 apply the protocol from chapter 2 to examine what effect 
perillyl alcohol and related compounds have on cell proliferation, migration and 
adhesion In human tumor and non-tumorlgenic breast cells. Finally, In chapter 4. 
I investigate the mechanism by which perillyl alcohol Inhibits cell migration In 
human tumor and non-tumorlgenic breast cells, specifically, alterations In RhoA 
protein Isoprenylation. Additionally, morphological changes In actin stress fiber 
and focal adhesion complex formation following treatment with perillyl alcohol are 
shown. These queries into how signal transduction pathways and cell 
morphology are affected by perillyl alcohol will aid in refining the search for 
potential anti-mlgratory compounds.
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Figure 1.1. A standard Costar transwell 12-filter migration plate showing 
individual filter inserts.
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Figure 1.2. 96-well migration plates are designed as a single insert containing 
all filter wells in one piece.
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Figure 1.3. Individual filter insert with fluorescence-opaque membrane. 
Fluorescent-labeled cells migrate across an opaque membrane toward stimulus 
present in media in feeder well. Emitted fluorescence of migrated cells is 
measured from underneath the filter.
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Figure 1.4. Diagram of integrin receptor-ECM interactions in migrating cell.
1. Cell is attached via integrin receptor ligation to ECM proteins on 
substratum which develops into focal adhesion complexes (blue). 2. Leading 
edge of cell moves forward forming new integrin-ECM contacts.
3. Contraction of cytoskeletal elements moves cytoplasm forward. 4. Focal 
adhesion complexes are released at the retracting edge of the cell. 5. 
Integrin receptors and associated proteins are recycled.
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Figure 1.5. Components of a focal adhesion complex assembled at the site of 
integrin-ECM contact.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20
CyclinDl
Myosin Light Chain^^ + Actin = Contraction ^
ERK
Myosin Light 
Chain Kinase
Myosin MEK 
Phosphatase
/
/
t
Myosin Light Chain 
= Relaxation t
CAMKU
tt JNK / Rho Kinase Grb2
tCalmodulinÎ
NaVtrPI3K^ Paxillin CAS t
FAK/SRC
Antiporter 
Caveolin
PKC4-TM4SF
Figure 1.6. Intracellular signaling pathways stimulated by integrin-ECM 
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Figure 1.7. Oxygenated monocyclic monoterpenes for which limonene serves as 
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CHAPTER 2
CONSTRUCTION OF A DRUG SCREEN FOR 
ANTI-MIGRATION DRUGS
Abstract
Metastasis of cancer cells greatly increases mortality. Many of the steps 
involved in cancer spread are potential targets for anti-metastatic treatment. We 
designed a protocol to screen for drugs with anti-migration effects. This assay 
required maximizing the migration of four representative cancer and non-cancer 
cell lines, and eliminating the confounding effects of dimethyl sulfoxide, a solvent 
used to solubilize the drugs for testing. We determined that all cell lines survived 
in at least 0.8% dimethyl sulfoxide by using the MTT cell viability assay Cell size 
was accounted for in making a monolayer of cells on the filter through which they 
migrate. Selection for extracellular matrix proteins for in vitro migration resulted 
in all four cell lines preferring fibronectin. Finally, migration on fibronectin in the 
presence of dimethyl sulfoxide was performed to establish the maximal 
percentage sustained without compromising cell migration. A percentage of
0.2% dimethyl sulfuoxide was innocuous to migration in all four cell lines. These 
findings support the application of this protocol in a large-scale drug screen for
22
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Introduction
Metastasis is the most deadly aspect of cancer. Localized primary tumors 
in non-vital organs, such as the skin, are not life threatening (1 ). Primary tumors 
can be surgically removed and the remaining local involvement can be treated 
with adjuvant chemotherapy and/or radiotherapy. However, if the primary tumor 
acquires the ability to invade its surrounding basement membrane layer of 
extracellular matrix (ECM) proteins and travels through blood and lymphatic 
vessels to new areas for colonization, it can then metastasize to form a 
secondary tumor with a much less certain prognosis for the patient. The 
progression from a primary to secondary tumor requires the completion of a 
sequential pathway, commonly referred to as a "cascade", and failure to 
complete any one step prevents metastasis (1 ). Metastatic cancer is difficult to 
treat and is usually fatal (1 ). Therefore, preventing the development of malignant 
tumors by inhibiting tumor cell migration is an important area of cancer research.
Understanding how cells migrate is also important for development of anti­
migration drugs. Cells move by extending the plasma membrane at the front of 
the cell into what is called lamellipodia. Polymerization of the actin cytoskeleton 
drives the extension of the lamellipodia, and it is stabilized by the formation of 
focal complexes (2). Integrin receptors, actin filaments and associated proteins 
are found grouped together in these focal complexes. As the cell advances 
forward, focal complex binding strength and organization increase (2), giving rise 
to focal adhesion complexes that provide points of traction over which the cell 
can move. Focal adhesion complexes link the cytoskeleton with the extracellular
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matrix through transmembrane integrin receptors to adapter proteins and various 
signaling molecules. Therefore, interfering with the turnover of focal adhesion 
and focal complexes could impede cell migration.
Research since 1978 has yielded fewer than 100 compounds that have 
some capacity to block cancer cell migration: however, thousands of compounds 
have yet to be tested. The reason for the limited number of identified inhibitors of 
tumor cell migration may be due to the technology used to detect them.
The majority of in vitro cell motility studies are conducted by using 
modified Boyden chambers in which cells are placed in the upper chamber and 
stimulated to move across the ECM - protein coated filter by haptotaxis: however, 
the methods by which migration is quantified is more diverse. Fixing, staining 
and manually counting the migrated cells under a light microscope is a common 
method (3-6). Binding migrated cells with a fluorescent tag, such as calcein-AM, 
and then quantifying fluorescence with an inverted microscope and computer 
program is another method (7-8). The migrated cells can also be removed with 
trypsin and counted in a Neubauer chamber (9-10). Time-lapsed 
videomicroscopy is an alternative technique for conducting cell motility assays. 
Cells are viewed with an inverted microscope, while a high-resolution black and 
white video camera and recorder record cell movement (11-12). These existing 
technologies for measuring cell migration are flawed because they require too 
much time and money to efficiently screen large numbers of compounds. One 
transwell plate, a modified-Boyden chamber, can hold 12 samples and costs $25. 
For example, screening 100 compounds using transwell plates would require
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several plates per compound with each insert handled separately. Time-lapsed 
videomicroscopy is also inadequate; it provides a detailed examination of 
individual cells, but is not an appropriate technology for screening large numbers 
of compounds.
We have developed an economical, accurate, high-throughput method for 
measuring in vitro cell migration. Our newly designed 96-well migration plate 
eliminates the handling of individual filters, reduces the number of cells and 
volume of drug sample used, and allows for many more replicates per treatment 
condition. The addition of an opaque filter on our plate, in conjunction with 
innocuous fluorescent cell labeling, provides the ability to perform quantify the 
number of migrated at any time point over the 18-hour migration assay. 
Measuring cell viability with assays such as the MTT test is also possible with our 
migration plate. Overall, through the application of new technology we should be 
able to expeditiously identify non-cytotoxic, migration-inhibiting compounds (15).
Prior to the commercialization of our new migration plate, we proceeded to 
develop a protocol for optimizing the conditions under which to screen for anti­
migration drugs. In this study, we established the preferred extacellular matrix 
protein for maximal cell migration, determined the cytotoxicity of dimethyl 
sulfoxide (DMSO), delineated the effect of DMSO on migration and measured the 
number of cells needed to form a monolayer of cells on the migration filter for one 
non-cancer and three cancer cell lines. DMSO is a commonly used as a drug 
solvent; therefore, we needed to account for its effect on cytotoxicity and cell 
migration. The three cell lines representing different types of cancers and the
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one non-cancer all preferred to migrate on fibronectin. DMSO cytotoxicity ranged 
from 0.8% to 2.0%. and migration was unaffected by DMSO in the range of 0.2% 
to 1.3% for all cell lines, respectively. With these defined parameters, we can 
apply them to our new migration plate and commence with a large-scale anti­
migration drug screen.
Materials and Methods 
Materials
SF-268, NCI-H460, MCF-7 and MCF-10A cells were purchased from 
American Type Culture Collection. Epidermal growth factor, cholera toxin, insulin 
were obtained from Calbiochem (La Jolla, CA). Horse serum was purchased 
from Irvine Scientific (Santa Ana, CA). Hydrocortisone, MTT (3-[4,5- 
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide: Thiazolyl blue) and DMSO 
(dimethyl sulfoxide) were purchased from Sigma-Aldrich Chemicals (St. Louis, 
MO). Calcein-AM was purchased from Molecular Probes (Eugene, OR). 
Transwell migration plates were purchased from Costar (Cambridge, MA). Cell 
culture flasks and 96-well plates were purchased from VWR (Plainfield, NJ).
Cell Culture
Cells were grown in 75 cm  ̂Falcon tissue-culture flasks and maintained at 
37° C and 5% CO2 in humidified chambers. NCI-H460 and SF-268 cells were 
maintained in Dulbecco's Modified Eagle’s Medium High Glucose supplemented 
with 10% fetal bovine serum purchased from Gemini Bio-Products. Inc. 
(Calabasas, CA) and 1% L-glutamine (29.2 mg/ml), penicillin G (10,000 units/ml)
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and streptomycin sulfate (10,000 mcg/ml) from Irvine Scientific (Santa Ana. CA). 
MCF-7 cells were maintained in RPMI Medium 1640 supplemented with 10% 
fetal bovine serum and 1% L-glutamine (29.2 mg/ml), penicillin G (10.000 
units/ml) and streptomycin sulfate (10,000 |ig/ml) from Irvine Scientific (Santa 
Ana, CA). MCF-10A cells were maintained in AM media—1:1 mixture of Ham’s 
F-12 medium and Dulbecco’s Modified Eagle’s Medium High Glucose with 2 mM 
L-glutamine from Irvine Scientific (Santa Ana, CA) supplemented with the 
following: epidermal growth factor (20 ng/ml), cholera toxin (100 ng/ml), insulin 
(0.01 mg/ml), hydrocortisone (500 ng/ml) and 5% horse serum. MDA-MB 435 
cells were maintained in RPMI Medium 1640 supplemented with 10% fetal 
bovine serum and 1% L-glutamine (29.2 mg/ml), penicillin G (10,000 units/ml) 
and streptomycin sulfate (10,000 iig/ml) from Irvine Scientific (Santa Ana, CA). 
Cells were routinely passaged using trypsin/EDTA from Irvine Scientific (Santa 
Ana. CA).
Cell Monolaver
Four replicates of 90-140 x 10  ̂cells in a 200 [il volume of media were 
seeded in a 96-well tissue culture plate. After a four-hour incubation at 37° C, 
cells were examined under an inverted microscope for evenly covering of the 
well’s 6 mm diameter surface. We extrapolated this number of cells to that 
needed to cover a 7 mm diameter of the filter on the transwell plate used in the 
migration assay.
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Cell Viability Assay 
The MTT assay is based on the cleavage of the yellow dye. 3-(4.5- 
dimethyl-2-thiazol)-2,5-diphenyl2H-tetrazolium bromide (MTT) to purple formazan 
crystals by the activity of the enzyme mitochondrial dehydrogenase. In replicates 
of 12 in a 96-well plate, 6x10'* cells were plated in 150 pi migration media 
(Dulbecco’s Modified Eagle’s Medium High Glucose supplemented with 1% L- 
glutamine (29.2 mg/ml), penicillin G (10,000 units/ml) and streptomycin sulfate 
(10,000 mcg/ml) from Irvine Scientific (Santa Ana. CA) and 0.1% bovine serum 
albumin from Boehringer Mannheim (Indianapolis, IN)) with varying 
concentrations of dimethyl sulfoxide (DMSO) and incubated for 18 hours at 37° C 
in a humidified 5% CO2 atmosphere. Three hours before the termination of the 
experiment, 50 ul of MTT dye (5 mg/ml) was added to each well and the plate 
was incubated for three hours. The reaction was stopped by removing 150 ul of 
the media and replacing it with 150 ul of acidic isopropanol (0.1 N hydrochloric 
acid in isopropanol) to each well. The plate was protected from light and 
incubated over night at room temperature. Absorbance was read at 570 nm in 
plate reader.
Migration Assay
Cell migration assays were performed as previously described in Costar 
transwell filter plates (15). Filters were either coated with purified ECM (collagen 
IV, fibronectin, laminin-1 or vitronectin) at a concentration of 20 pg/ml in 
carbonate buffer (pH 9.3) for 1 hour at room temperature. Filters were then 
aspirated and blocked in blotto (phosphate-buffered saline with 0.2% Tween-20
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(PBST) and 5% skim milk) for 1 hour at room temperature. Next filters were 
washed in PBST prior to the assay. Thirty minutes prior to starting the assay 
cells were pre-incubated at 37° C in migration media and varying concentration 
of DMSO. Cells were seeded at a concentration of either 1.2 or 1.8 x 10®. 
depending on cell line, on the transwell filters with and without ECM in the 
presence or absence of soluble growth factors (serum-enriched media) and 
varying concentrations of DMSO and allowed to migrate for 18 hours at 37° C in 
5% CO2 Thirty minutes before measuring migration, 5 pM of calcein-AM. a 
fluorescent dye that chelates calcium, (Molecular Probes; Eugene.OR) was 
added to the migration wells. To quantify migration, cells were removed from the 
top of the filter with cotton swabs, filters were washed in phosphate-buffered 
saline and migrated cells were measured from the bottom of the filter with a plate 
reader for the incorporation of calcein-AM (14). Relative fluorescence values for 
each experimental condition were expressed relative to control, untreated 
samples.
Results
We tested the toxicity of DMSO, due to the use of DMSO in drug 
packaging for screening, in four representative cell lines. Cell viability was 
assessed by the ability to metabolize MTT, which was measured by increased 
absorbance by a plate reader. The NCI-H460 cell line, small cell lung carcinoma 
tolerated less than 1% DMSO (Fig. 2.1), and the SF-268 cell line, neuronal 
sarcoma, showed a tolerance for DMSO of 2% or less in concentration (Fig. 2.2).
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The third cancer cell line, MCF-7, breast carcinoma, was less tolerant of DMSO 
with only surviving a concentration of up to 1% or less (Fig. 2.3). The final cell 
line tested was MCF-10A, a representative of normal non-cancerous. 
immortalized breast cells, which was the least able to tolerate DMSO at 0.8% or 
less (Fig. 2.4).
To maximize the migration of these four cell lines we performed in vitro 
migration assays to identify their preference for extracellular matrix protein out of 
collagen IV, fibronectin, laminin-1 and vitronectin. Blotto was used as a negative 
control for non-specific binding and media containing serum was used as a 
positive control. All of the four cell lines migrated most toward fibronectin (Fig.
2.5-2.8).
In order to account for any effect that DMSO may have on migration, cells 
were migrated on fibronectin with up to the previously determined amount of 
DMSO that did not affect cell viability. For MCF-10A cells migration was normal 
in media with DMSO equal to or less than 0.2% (Fig. 2.9). The amount of DMSO 
that did not interfere with migration was equal to or less than 0.5% for both NCi- 
H460 (Fig. 2.10) and SF-268 (Fig. 2.11) cell lines, while less than 0.5% had no 
effect on the MCF-7 cell line’s migration (Fig. 2.12).
Additionally, it was necessary to determine the number of cells needed to 
form a monolayer on the filters used in the migration assay. Three of the cell 
lines required 120.000 cells to evenly cover the filter. However, the NCI-H460 
cells were smaller and took 180,000 cells (Table 2.1).
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Discussion
Two important properties of malignant cancer cells are their ability to 
invade surrounding tissues through a basement membrane (16) and their ability 
to form metastatic foci at distant sites (17); a process requiring tumor cells to 
detach from the ECM of the primary tumor and to migrate to other sites. It Is 
supposed that increased cell motility facilitates invasion and metastasis of 
malignant tumors (16). Inhibiting cancer cell migration and metastasis could 
effectively eliminate the most deadly aspect of the disease (18).
We previously designed a new 96-well plate for use as a tool for 
measuring both cell migration inhibition and cell death in cancer cell lines when 
treated with anti-cancer compounds (14). In conjunction with our new plate, we 
also developed an economical, accurate method for measuring cell migration 
(14). In this study, we defined the conditions necessary for optimizing our high- 
throughput assay to screen for anti-cancer compounds for their ability to stop cell 
migration of established cell lines in vitro.
We determined that the concentration of DMSO that induces cell death in 
our representative cell lines is greater than the concentration measured for any 
detectable impairment in cell migration. Although our use of DMSO is only as a 
probable solvent used for drug packaging and not as an agent for inhibiting cell 
migration, our results confirm that this assay system is capable of identifying non- 
cytotoxic, anti-migration compounds (14). We also established that it is possible 
to use DMSO as a solvent and delineate its effect on migration from those of 
tested anti-cancer compounds.
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Another parameter in question for conducting an anti-migration drug 
screen is selection of preferred extracellular matrix protein. It is well known that 
the motility of several normal cells and tumor cells is regulated by ECM proteins 
such as fibronectin, laminin, vitronectin and type-IV collagen (19). These 
proteins stimulate chemotaxis (motility toward a chemical gradient) and 
haptotaxis (motility stimulation toward a bound substrate) (20). Our cell lines 
represent two carcinomas and one sarcoma, as well as a non-tumorigenic breast 
cell line. All four cell lines showed a preference for migrating on fibronectin, 
which aids in simplifying the migration assay for a drug screen.
Determining cell size is also of importance for performing the migration 
assay. Plating the cells to form a monolayer on the top of the filter for the 
migration assay is necessary to mimic in vivo conditions. Among our cell lines 
the small cell carcinoma (NCI-H460) cells are approximately two thirds the size of 
the other cell lines.
In summary, we demonstrated that it is possible to optimize our high- 
throughput assay for screening potential antimigratory compounds. Using four 
cell lines designated by the National Cancer Institute, we were able to discern 
between the cytotoxicity of DSMO and its effect on migration in our assay, which 
is necessary due to the use of DMSO as a drug solvent. According to our results 
from this study we would be able to proceed with screening anticancer 
compounds held by such institutions as the National Cancer Institute when our 
96-well migration plate becomes commercially available.
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Figure 2.1. NCI-H460 cells survived 18 hours of exposure to < 1% DMSO. 
Bars are mean ± SO absorbance. Bars with the same letter were not 
significantly different from each other. In DMSO, differences were significant 
[analysis of variance (ANOVA) F[6,41] = 556.37, P < 0.0001, n = 7/bar]. A 
student-Numan-Keuls test (SNK) identified four groups (P < 0.05).
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Figure 2.2. SF-268 cells survived 18 hours of exposure to < 2% DMSO. Bars 
are mean ± SD absorbance. Bars with the same letter or letters were not 
significantly different from each other. In DMSO, differences were significant 
[analysis of variance (ANOVA) F[6,27] = 19.18, P < 0.0001, n = 4/bar]. A 
student-Numan-Keuls test (SNK) identified two partly overlapping groups and 
one other group (P < 0.05).
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Figure 2.3. MCF-7 cells survived 18 hours of exposure to < 1% DMSO. Bars 
are mean ± SD absorbance. Bars with the same letter were not significantly 
different from each other. In DMSO, differences were significant [analysis of 
variance (ANOVA) F[6,54] = 381.60, P < 0.0001, n = 8/bar]. A student- 
Numan-Keuls test (SNK) identified six groups (P < 0.05).
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Figure 2.4. MCF-10A cells survived 18 hours of exposure to < 0.8% DMSO. 
Bars are mean ± SD absorbance. Bars with the same letter were not 
significantly different from each other. In DMSO, differences were significant 
[analysis of variance (ANOVA) F[6,55] = 436.37, P < 0.0001, n = 8/bar]. A 
student-Numan-Keuls test (SNK) identified four groups (P < 0.05).
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Figure 2.5. MCF-7 cells preferentially migrated on fibronectin. Fluorescence 
was measured at 485 nm for excitation and at 530 nm for emission. Bars are 
mean ± SD relative fluorescent units (RFU). Bars with the same letter were not 
significantly different from each other. On extracellular matrix proteins, 
differences were significant [analysis of variance (ANOVA) F[5, 23] = 459.93, P 
< 0.0001, n = 4/bar]. A student-Numan-Keuls test (SNK) identified five groups 
(P<0.05).
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Figure 2.6. SF-268 cells preferentially migrated on fibronectin and collagen 
IV. Fluorescence was measured at 485 nm for excitation and at 530 nm for 
emission. Bars are mean ± SD relative fluorescent units (RFU). Bars with the 
same letter or letters were not significantly different from each other. On 
extracellular matrix proteins, differences were significant [analysis of variance 
(ANOVA) F[5, 23] -  23.11, P < 0.0001, n = 4/bar]. A student-Numan-Keuls 
test (SNK) identified two partly overlapping groups and one other group (P < 
0.05).
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Figure 2.7. NC1-H460 cells preferentially migrated on both fibronectin and 
vitronectin. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Bars are mean ± SD relative fluorescent units (RFU). Bars 
with the same letter were not significantly different from each other. On 
extracellular matrix proteins, differences were significant [analysis of variance 
(ANOVA) F[5,23] = 57.15, P < 0.0001, n = 4/bar]. A student-Numan-Keuls test 
(SNK) identified three groups (P < 0.05).
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Figure 2.8. MCF-10A cells preferentially migrated on fibronectin. Fluorescence 
was measured at 485 nm for excitation and at 530 nm for emission. Bars are 
mean ± SD relative fluorescent units (RFU). Bars with the same letter were not 
significantly different from each other. On extracellular matrix proteins, 
differences were significant [analysis of variance (ANOVA) F[5,23] = 591.80, P 
< 0.0001, n = 4/bar]. A student-Numan-Keuls test (SNK) identified six groups 
(P<0.05).
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Figure 2.9. Migration of MCF-10A cells was unaffected by < 0.2% DMSO on 
fibronectin. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Bars are mean ± SD relative fluorescent units (RFU). Bars 
with the same letter or letters were not significantly different from each other. 
In DMSO and on fibronectin, differences were significant [analysis of variance 
(ANOVA) F[7, 23] = 104.42, P < 0.0001, n "  3/bar]. A student-Numan-Keuls 
test (SNK) identified two partly overlapping groups and two other groups (P < 
0.05).
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Figure 2.10. Migration of NCI-H46G cells was unaffected by < 0.5% DMSO on 
fibronectin. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Bars are mean ± SD relative fluorescent units (RFU). Bars 
with the same letter were not significantly different from each other. In DMSO 
and on fibronectin, differences were significant [analysis of variance (ANOVA) 
F[5,23] = 69.59, P < 0.0001, n = 4/barj. A student-Numan-Keuls test (SNK) 
identified four groups (P < 0.05).
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Figure 2.11. Migration of SF-268 cells was unaffected by < 0.5% DMSO on 
fibronectin. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Bars are mean ± SD relative fluorescent units (RFU). Bars 
with the same letter were not significantly different from each other. In DMSO 
and on fibronectin, differences were significant [analysis of variance (ANOVA) 
F[7, 23] = 55.55, P < 0.0001, n = 3/bar]. A student-Numan-Keuls test (SNK) 
identified five groups (P < 0.05).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
46
3
U.
C
35000
30000 -
25000 -
20000 -
15000 i
10000
5000
blotto serum 0% .5%
[DMSO]
1% 2%
Figure 2.12. Migration of MCF-7 cells was unaffected by < 0.5% DMSO on 
fibronectin. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Bars are mean ± SD relative fluorescent units (RFU). Bars 
with the same letter were not significantly different from each other. In DMSO 
and on fibronectin, differences were significant [analysis of variance (ANOVA) 
F[5,23] = 76.91, P < 0.0001, n = 4/bar]. A student-Numan-Keuls test (SNK) 
identified four groups (P < 0.05).
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condition tests MCF-10A MCF-7 SF-268 NCI-H460
DMSO%
cell
viability <  0.8% < 1% < 2 % <1%
DMSO% migration <  0.2% < 0.5% <  0.5% <  0.5%
ECM
selection migration fibronectin fibronectin
fibronectin 
collagen IV
fibronectin
vitronectin
monolayer 120.000 120,000 120.000 180,000
Table 2.1. Summary of optimized parameters for a large-scale drug screen for 
anti-migration compounds: All cell lines were viable in < 2% DMSO for 18 hours, 
preferentially or equally on migrated on fibronectin as compared to other ECM 
proteins and their migration was unaffected in < 0.5% DMSO. The number of 
cells needed to form a monolayer that evenly covers the migration filter was 
greater for the NCI-H460 cell line compared to the other cell lines.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 3
IDENTIFICATION OF PERILLYL ALCOHOL AS A 
CELL-MIGRATION-INHIBITING DRUG
Abstract
Chemotherapeutic and chemopreventive effects of llmonene have been 
demonstrated in breast cancer with tumor regression and low toxicity. The 
monoterpene d-iimonene and its related compounds, perillyl alcohol and 
perillaidehyde were chosen as candidate drugs for application in the anti­
migration drug screen assay. Using a human breast non-tumorigenic cell line 
MCF-10A, we investigated the toxicity of these compounds in a 24-hour cell 
growth assay. Results delineated toxicity as greatest for perillaidehyde, 
intermediate for perillyl alcohol and least for limonene. A haptotactic in vitro 
migration assay of MCF-10A cells with limonene and perillyl alcohol revealed that 
a non-cytotoxic concentration of 0.5 mM perillyl alcohol inhibited migration, while 
the same concentration of limonene failed to do so. Adhesion in the MCF-10A 
cell line and a human breast cancer cell line MDA-MB 435 was unaffected by 1.5 
mM perillyl alcohol. Growth was inhibited in MDA-MB 435 cells at a concentration 
of 0.4 mM perillyl alcohol. A non-cytotoxic and migration-inhibiting concentration 
of perillyl alcohol was undetected for MDA-MB 435 ceils. Our results for
48
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cytotoxicity in cancer and non-cancer cells corroborate findings of prior research. 
The novel obsen/ation that perillyl alcohol inhibits cell migration at a non-toxic 
dose may bear further fruit in deciphering an underlying mechanism for impeding 
cell migration.
Introduction
Identifying drugs that inhibit tumor cell migration has been limited by the 
lack of available technology. To date fewer than 100 compounds have been 
shown to possess anti-migration properties against cancer cells, while 
researchers have discovered thousands of anti-proliferative drugs. Current 
methods of measuring cell migration employ techniques that require copious 
amounts of time and money to generate effective data. The most popular device 
used is the “Transwell” or “modified Boyden chamber^ that consists of 24 
individual filter inserts and costs $25 per plate. Our lab has developed an 
automated, high-throughput in vitro cell migration/cytotoxicity assay to improve 
efficiency and costs involved in screening drugs for potential anti-migration 
effects.
Our migration assay is based on a common technique of measuring cells 
that move through a porous membrane. However, instead of counting stained 
cells manually under a microscope, which is time consuming and less precise, 
we label the migrated cells with a fluorescent tag, such as calcein-AM (Molecular 
Probes; Eugene, OR) and a plate reader accurately measures the level of 
fluorescence in seconds. Another novel feature of our assay is that it can be
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used with the 96-well migration plate designed by our lab. Multiple replicates can 
be screened in much less time because our plate does not have individual filters 
but rather a single mold with 96-wells. The opaque filter on our plate is also 
unique. Being able to measure fluorescence from the top and bottom of the filter 
will allow us to test for cytoxicity with a compound such as MTT and cell 
migration with calcein-AM in the same well (8).
Prior to the manufacturing of our new plate, we used Transwell plates to 
complete the optimization of the conditions for cancer and non-cancer cell 
migration with our new protocol. These conditions include identifying which 
extracellular matrix protein to coat the filters with to maximize migration for 
different cell lines, measuring cytotoxicity due to dimethyl sulfoxide (DMSO) 
exposure, and accounting for the effect of DMSO on migration. DMSO is a 
common solvent used to solubilize compounds.
In this study, we applied the cytotoxcity and migration assays to screen 
drugs, already known to have anti-cancer effects, for anti-migration properties. 
The chemotherapeutic and chemopreventative effects of d-limonene, a 
monoterpene found in the essential oils of citrus fruits, spices and herbs, have 
been studied extensively in spontaneous and chemically induced rodent tumors 
(1 ). Limonene serves as a precursor to other oxygenated monocyclic 
monoterpenes such as carved, can/one, menthol, perillyl alcohol and 
perillaidehyde (2). Due to success in tumor regression in various rodent cancer 
types, clinical testing of the cancer chemotherapeutic activity of limonene and
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perillyl alcohol is in progress (3-4), though their exact mechanism of action 
remains unknown.
We chose to investigate three related compounds, limonene. perillyl 
alcohol and perilladehyde, for possible anti-migration effects in human breast 
cancerous (MDA-MB 435) and non-cancerous (MCF-10A) cells. Prior to 
assessing inhibition of migration, we measured the cytotoxicity of these 
compounds, finding that perillaidehyde was lethal at all tested concentrations.
We proceeded next to investigate limonene and perillyl alcohol’s effect on MCF- 
10A cell migration. At a concentration of 1.0 mM. limonene did not affect 
migration. However, a non-cytotoxic concentration of perillyl alcohol decreased 
MCF-10A cell migration. Unfortunately, migration of MDA-MB 435 cells was not 
inhibited without compromising cell viability. Additionally, adhesion in both cell 
lines was unaffected by concentrations of perillyl alcohol relevant to the 
measured anti-migration activity of MCF-10A cells. The results of this 
investigation suggest that perillyl alcohol has diverse effects on migration in 
different cell lines. One possible mechanism of action of perillyl alcohol may 
involve reduction in the isoprenylation of G proteins such as RhoA (5), which may 
lead to inhibition of cell migration.
Materials and Methods 
Materials
MCF-10A and MDA-MB 435 cells were purchased from American Type 
Culture Collection. Epidermal growth factor, cholera toxin, insulin were obtained
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from Calbiochem (La Jolla, CA). Hydrocortisone was purchased from Sigma- 
Aldrich Chemicals (St. Louis, MO). Horse serum was purchased from In/ine 
Scientific (Santa Ana, CA). Calcein-AM was purchased from Molecular Probes 
(Eugene, OR). Transwell migration plates were purchased from Costar 
(Cambridge, MA). Cell culture flasks and 96-well plates were purchased from 
VWR (Plainfield, NJ). Limonene, perillyl alcohol, perillyl aldehyde were 
purchased from Aldrich Chemical Co. (Milwaukee, Wl).
Cell Culture
Cells were grown in 75 cm  ̂Falcon tissue-culture flasks and maintained at 
37° C and 5% CO2 in humidified chambers. MCF-10A cells were maintained in 
AM media—1:1 mixture of Ham's F-12 medium and Dulbecco’s Modified Eagle’s 
Medium High Glucose with 2 mM L-glutamine from Irvine Scientific (Santa Ana, 
CA) supplemented with the following: epidermal growth factor (20 ng/ml), cholera 
toxin (100 ng/ml), insulin (0.01 mg/ml), hydrocortisone (500 ng/ml) and 5% horse 
serum. MDA-MB 435 cells were maintained in RPMI Medium 1640 
supplemented with 10% fetal bovine serum and 1% L-glutamine (29.2 mg/ml), 
penicillin G (10,000 units/ml) and streptomycin sulfate (10,000 ng/ml) from Irvine 
Scientific (Santa Ana, CA). Cells were routinely passaged using trypsin/EDTA 
from Irvine Scientific (Santa Ana, CA).
Proliferation Assay 
In 96-well plates 3x10^ cells were seeded in the appropriate serum- 
containing media and incubated for 2 hours at 37° C and 5% CO2 in humidified 
chambers. Cells were then washed twice with PBS and grown in migration
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media (MCF-10A: DMEM and 0.1% BSA; MDA-MB 435; RPM11640 and 0.1% 
BSA) with indicated concentrations of limonene, perillyl alcohol or perillaidehyde 
for 24 hours. Cells were washed twice with PBS, fixed in 3.7% formaldehyde for 
15 minutes, stained with crystal violet and lysed with 1% sodium docecyl sulfate 
(SDS). Absorbance was read at 595 nm using a plate reader. Growth was 
measured as compared to a standard curve of cells grown in serum-containing 
media.
Adhesion Assav
Cell adhesion assays were performed as previously described in Costar 
96-well Cell Culture Cluster plates (6). Tissue culture plates were either coated 
with purified fibronectin at a concentration of 20 pg/mL for 1 hour at room 
temperature. Wells were then washed with phosphate-buffered saline with 0.2 % 
Tween-20 (PBST), blocked with 5 % blotto (PBST with 5% skim milk) for one 
hour at 25° C. Wells were then washed twice with PBST prior to assay. Cells 
were seeded at a concentration of 1 x 10° in cell culture plates in migration media 
(for MCF-10A; DMEM and 0.1% BSA; for MDA-MB 435; RPM11640 and 0.1% 
BSA) with or without perillyl alcohol and were allowed to attach for eighteen 
hours at 37° C in a humidified incubator containing 5% COz Unbound cells were 
dislodged by inverting, submerging and rocking the plate in PBS for 15 minutes. 
Cells were then fixed in 3.7% formaldehyde, stained with crystal violet and lysed 
with 1% SDS. Absorbance was measured at 595 nm in a plate reader.
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Migration Assav
Cell migration assays were performed as previously described in Costar 
transwell filter plates (7). All filters except for the negative control.blotto, were 
coated with purified fibronectin at a concentration of 20 pg/ml in carbonate buffer 
(pH 9.3) for 1 hour at room temperature. Filters were then aspirated and blocked 
in blotto (phosphate-buffered saline with 0.2% Tween-20 (PBST) and 5% skim 
milk) for 1 hour at room temperature. Next filters were washed in PBST prior to 
the assay. Thirty minutes prior to starting the assay cells were pre-incubated at 
37° C in migration media and varying concentrations of perillyl alcohol. Cells 
were seeded at a concentration of either 1.2 x 10° on the transwell filters with 
and without ECM in the presence or absence of soluble growth factors (serum- 
enriched media) and varying concentrations of POH and allowed to migrate for 
18 hours at 37°C in 5% CO2. Thirty minutes before measuring migration, 5 pM of 
calcein-AM, a fluorescent dye that chelates calcium, (Molecular Probes:
Eugene,OR) was added to the migration wells. To quantify migration, cells that 
did not migrate were removed from the top of the filter with cotton swabs, filters 
were washed in phosphate-buffered saline and migrated cells were measured 
from the bottom of the filter with a plate reader for the incorporation of calcein-AM 
(8). Fluorescence values for each experimental condition were expressed 
relative to control, untreated samples.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
55
Results
The monoterpene d-iimonene and its related compounds, perillyl alcohol 
and perillaidehyde, showed substantial differences in a 24-growth assay. 
Cytotoxicity was determined by comparing absorbance readings of crystal violet 
as related to cell number for a standard curve of cells grown in migration media 
alone. MCF-10A cells exposed to 0.5 mM perillaidehyde and 1.0 mM perillyl 
alcohol could not grow or survive (Fig. 3.1). However, migration media with 
limonene tested up to 1.0 mM was innocuous, allowing the cells to replicate as 
normal.
Haptotactic migration assays using perillyl alcohol and limonene with 
MCF-10A cells on fibronectin to determine if either compound could inhibit cell 
migration established perillyl alcohol as such a compound. Limonene was 
unable to affect migration at the 1.0 mM maximum concentration tested, while 
perillyl alcohol decreased migration at 0.5 mM, a non-cytotoxic dose (Fig. 3.2).
To test the effect of perillyl alcohol on adhesion both non-cancerous 
(MCF-10A) cells and cancerous (MDA-MB 435) cells were used. Over an 18- 
hour exposure to increasing concentrations of perillyl alcohol, both MCF-10A and 
MDA-MB 435 cell lines tolerated up to 1.5 mM without a significant difference 
compared to 0 mM (Fig. 3.3).
Growth and migration assays were performed for both cell lines. In MCF- 
10A cells migration was inhibited at a concentration of 0.5 mM of perillyl alcohol. 
Cell viability for MCF-10A cells, as measured as not less than baseline of 30 x 
10° cells, was stable in 0.75 mM of perillyl alcohol (Fig. 3.4). For MDA-MB 435
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cells, migration was not inhibited by perillyl alcohol at a concentration that was 
also not cytotoxic (Fig. 3.5).
Discussion
We have shown that the monoterpene perillyl alcohol (POH), unlike its 
other related compounds limonene and perillaidehyde, can inhibit migration in the 
nontumorigenic MCF-10A human breast cell line. This inhibition is induced by a 
concentration of POH that is not cytotoxic or cytostatic. Our results from a 24- 
hour growth assay demonstrate that perillaidehyde is considerably more toxic 
than either perillyl alcohol or limonene. This may be due to increased affinity 
between perillyl aldehyde and the enzymes famesyl transferase (FT) and 
geranylgeranyl transferase (GGT) as has been shown for the minor metabolite, 
perillic acid methyl ester, of limonene and POH (9). These enzymes are involved 
in post-translational modification of small G-proteins that are involved in a myriad 
of cell activities such as growth and migration. Inhibition of FT and GGT is 
suspected to be the basis of the anti-tumor effects of perillyl alcohol and 
limonene (9). However, as shown by our results and in accord with others, an 
equal concentration of limonene is not as effective in blocking cell proliferation as 
perillyl alcohol (2.9).
Migration of MCF-10A cells was also unaffected by treatment with 1.0 mM 
limonene whereas 0.5 mM perillyl alcohol markedly reduced it. Again, this 
difference is most likely attributable to the limonene metabolites and perillyl 
alcohol having a greater potency than limonene in the inhibition of small G-
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protein isoprenylation (1,10). A probable mediator of this inhibited migration is 
the small G-protein RhoA, a member of the Rho family of small GTPases that is 
involved in a signaling pathway for cell migration (5,11 ).
Adhesion in MCF-10A cells is more tolerant of perillyl alcohol treatment.
At 1.5 mM, adhesion was unaffected unlike the decreased migration measured at
0.5 mM POH. Even in the cancer cell line, adhesion was maintained. The 
requirements for adhering to a surface are much less demanding on the cell than 
migrating. Adhesion is a static activity and migration is a highly coordinated 
kinetic action of many structural and signaling proteins.
To further assess POH as a possible inhibitor of cancer cell migration we 
tested it in the human breast cancer cell line MDA-MB 435. Our results show 
that POH is unable to block migration at a non-cytotoxic level in this cell line.
This may be due to this cell line expressing a higher level of RhoA as has been 
reported in other tumor cells as compared to nontumorigenic cells (12). An 
increased invasive phenotype is also characteristic of some liver and breast 
tumor cells in response to RhoA activation (12-13). Additionally, research has 
shown that perillyl alcohol treatment significantly increased apoptosis in 
pancreatic cancer cells relative to non-malignant pancreas cells (14). Thus, our 
results with POH treatment in MDA-MB 435 cells may not be attributable to the 
same mechanism as that in nontumorigenic MCF-10A cells.
In conclusion, we have shown that perillyl alcohol is a non-cytotoxic, anti­
migration agent in the human breast cell line MCF-10A. This inhibition was not 
seen in the cancer cell line MDA-MB 435, which may be due to greater
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expression of RhoA and increased activation/deactivation of other signaling 
pathways sensitive to perillyl alcohol treatment. From this point, it seems 
reasonable to further investigate the involvement of RhoA protein in the POH- 
treated MCF-10A decreased cell migration.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
References
1. Crowell, P.L and M.N. Gould. 1994 Chemopreventlon and therapy of cancer 
d-. limonene. Critical Reviews in Oncogenesis. 5:1-22.
2. Crowell, P.L 1999 Prevention and therapy of cancer by dietary 
monoterpenes. Journal of Nutrition. 129:7758-7788.
3. Vigushin, D.M., Poon, G.K., Boddy, A., English, J., Halbert. G.W., Pagonis.
C., Jarman, M. and R.C. Coombes. 1998 Phase 1 and pharmokinetic study of 
d-limonene in patients with advanced cancer. Cancer Chemotherapeutics and 
Pharmacology. 42:111-117.
4. Phillipos, L.R., Malspeis, L. and J.G. Supko. 1995 Pharmokinetics of active 
drug metabolites after oral administration of perillyl alcohol, an investigational 
antineoplastic agent, to the dog. Drug Metabolism and Disposal. 23:676-80.
5. Ren, Z., Elson, C.E. and M.N. Gould. 1997 Inhibition of type I and type II 
geranylgeranyl-protein transferases by monoterpene perillyl alcohol in 
NIH3T3 cells. Biochemical Pharmacology. 54:113-120.
6. Plopper, G.E., McNamee, H P., Dike, L.E., Bojanowski, K. and D.E. Ingber. 
1995 Covergence of integrin and growth factor receptor signaling pathways 
within the focal adhesion complex. Molecular Biology of the Cell. 6:1349- 
1365.
7. Plopper. G.E., Domanico, 8.Z., Cirulli, V., Kioses, W.B. and V. Quaranta. 
1998 Migration of breast epithelial cells on integrins: differential role of 
integrins in normal and transformed cell types. Breast Cancer Research. 
51:57-69.
8. Rust. W .L. Huff. J.L and G.E. Plopper. 2000 Screening assay for 
promigratory/antimigratory compounds. Analytical Biochemistry. 280:11-19.
9. Gelb, M., Tamanoi, P., Yokoyama, K., Ghomashchi, P., Esson, K. and M.N. 
Gould. 1995 The inhibition of protein prenyltransferases by oxygenated 
metabolites of limonene and perillyl alcohol.
10. Crowell, P.L, Ren,Z., Lin, 8., Vedejs. E., and M.N. Gould. 1994 Structure- 
activity relationships among monoterpene inhibitors of protein isoprenylation 
and cell proliferation. Biochemical Pharmacology. 47:1405-1415.
11. [Roller, L. and A. Hall. 1999 Signaling to Rho GTPases. Experimental Cell 
Research. 253:166-179.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
60
12.Yoshioka. K., Nakamori, S. and K. Itoh. 1999 Overexpression of small GTP- 
binding protein RhoA promotes invasion of Tumor cells. Cancer Research. 
59:2004-2010.
13. Bourguignon, L, Zhu, H., Shao, L, Zhu, D. and Y. Chen. 1999 Rho-kinase 
(ROK) promotes CD44v3.8-io-ankyrin interaction and tumor cell migration in 
metastatic breast cancer cells. Cell Motility and the Cytoskeleton. 43:269-287.
14. Stayrook, K.R., McKinzie, J.H., Burke, Y.D., Burke, Y.A. and P.L. Crowell.
1997 Induction of the apoptosis-promoting protein Bak by perillyl alcohol in 
pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial 
cells. Carcinogenesis. 18:1655-1658.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
■ H  Migration media 
EZZa Limonene 
I I Perillyl alcohol 
Perillaidehyde
70
60 -
50 -
n
®  40 
K
® 30 
ü
20 -
10
A 
1D
É
B
%
I
0 mM 0.5 mM 0.75 mM 1.0 mM
[monoterpenes]
Figure 3.1. MCF-10A cells replicated as normal when exposed to 1.0 mM 
limonene and 0.5 mM perillyl alcohol. All tested concentrations of 
perillaidehyde showed a dose-dependent increase in cytotoxicity; 1.0 mM killed 
all of the plated cells. Migration media represents untreated condition. Dotted 
line represents the number of cells initially plated. Bars are mean ± SD number 
of cells. Bars with the same letter were not significantly different from each 
other. In the various treatment conditions, differences were significant 
[analysis of variance (ANOVA) F[9, 98] = 121.63, P < 0.0001, n = 10/bar]. A 
student-Numan-Keuls test (SNK) identified five groups (P < 0.05).
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Figure 3.2. Migration of MCF-10A cells was inhibited by 0.5 mM perillyl alcohol 
on fibronectin, whereas 1.0 mM limonene failed to slow cell migration under the 
same conditions. Fluorescence was measured at 485 nm for excitation and at 
530 nm for emission. Bars are mean ± SD relative fluorescent units (RFU). 
Bars with the same letter were not significantly different from each other. In 
treatment conditions and on fibronectin, differences were significant [analysis of 
variance (ANOVA) F[7, 23] = 231.76, P < 0.0001, n = 3/bar]. A student- 
Numan-Keuls test (SNK) identified five groups (P < 0.05).
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Figure 3.3. Adhesion on fibronectin of MCF-10A cells (gray bars) and MDA-MB 
435 cells (black bars) was unaffected by 1.5 mM perillyl alcohol in migration 
media after 18 hours of exposure. Bars are mean ± SD absorbance. Bars with 
the same letter or letters were not significantly different from each other. In 
treatment conditions and on fibronectin, differences were significant [analysis of 
variance (ANOVA) F; (MCF-10A) [6, 55] = 144.88, P < 0.0001, n = 8/ban (MDA- 
MB 435) [6,41] = 252.45, P < 0.0001, n = 7/bar]. A student-Numan-Keuls test 
(SNK) identified: (MCF-10A) two partly overlapping groups and two other groups; 
(MDA-MB 435) four groups (P < 0.05).
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Figure 3.4. Migration and growth assays with MCF-10A cells exposed to 
increasing concentrations of perillyl alcohol (POH) established that at 0.5 mM 
cells were still replicating while their migration was inhibited. Blotto is a 
negative control. Dotted line represents the initial number of cells plated for the 
growth assay. Migration assay did not include POH concentrations of 0.25 mM 
and 0.75 mM. Fluorescence was measured at 485 nm for excitation and at 530 
nm for emission. Migration: Bars are mean ± SD relative fluorescent units 
(RFU). Bars with the same upper case letter or letters were not significantly 
different from each other. In treatment conditions and on fibronectin, 
differences were significant [analysis of variance (ANOVA) F: [6, 20] = 33.80, P 
< 0.0001, n = 4 or 2/bar. A student-Numan-Keuls test (SNK) identified two 
partly overlapping groups and two other groups (P < 0.05). Growth assay for 
1.5 mM and 2.0 mM POH severely reduced the number of viable cells. Cell 
number was determined using a standard curve and measured by absorbance 
at 595 nm. Growth: Bars are mean ± SD number of cells. Bars with the same 
lower case letter were not significantly different from each other. In treatment 
conditions, differences were significant [analysis of variance (ANOVA) F: [7, 79] 
= 253.58, P < 0.0001, n = 10/bar. A student-Numan-Keuls test (SNK) identified 
six groups (P < 0.05)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
65
60000 60
a
A 1 i___ 1 ürowtn
50000 -
■ B  Migration
3  40000 -
O 30000 -
S  20000
10000  -
li
no
K
=O
o
0- O'
[POH]
Figure 3.5. Migration and growth assays with MDA-MB 435 cells exposed to 
various concentrations of perillyl alcohol (POH) established that there was not 
a non-cytotoxic concentration of POH that could inhibit migration. Blotto is a 
negative control for the migration assay. Dotted line represents the initial 
number of cells plated for the growth assay. Migration assay did not include 
POH concentrations greater than 0.5 mM. Fluorescence was measured at 485 
for excitation and at 530 nm for emission. Migration: Bars are mean ± SO 
relative fluorescent units (RFU). Bars with the same upper case letter were not 
significantly from each other different. In treatment conditions and on 
fibronectin, differences were significant [analysis of variance (ANOVA) F: [6, 
23] = 33.80, P < 0.0001, n = 4 or 2/bar. A student-Numan-Keuls test (SNIQ 
identified four groups (P < 0.05). Growth assay does not include a 0.1 mM 
POH concentration. For the growth assay, the number of cells was determined 
by a standard curve using absorbance measured at 595 nm. Growth: Bars are 
mean ± SD number of cells. Bars with the same lower case letter were not 
significantly different from each other. In treatment conditions, differences 
were significant [analysis of variance (ANOVA) F: [7, 80] = 56.08, P < 0.0001, 
n = 10/bar. A student-Numan-Keuls test (SNK) identified five groups (P < 
0.05).
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CHAPTER 4
DETERMINATION OF THE MECHANISM BY 
WHICH PERILLYL ALCOHOL INHIBITS 
BREAST CELL MIGRATION
Abstract
Perillyl alcohol is currently in clinical trials for prevention and treatment of 
various cancers. One of the identified cellular activities of perillyl alcohol is the 
inhibition of the enzyme type 1 geranylgeranyl transferase. RhoA is a protein 
that requires prénylation to be active and to initiate a pathway involved in cell 
migration. We hypothesized that the decreased migration observed in POH- 
treated MCF-10A and MDA-MB 435 cells would be the result of the translocation 
of RhoA to the cytosol, thus impairing its migration signaling pathway. In this 
study, we first measured by western blot whether exposure to perillyl alcohol 
down-regulated the production of RhoA protein in human breast non-tumorigenic 
MCF-10A and MDA-MB 435 breast cancer cells and found that it did not. We 
also found that RhoA protein expression was greater in the non-cancerous MCF- 
10A cells than the MDA-MB 435 cells. Next the distribution of RhoA protein 
between the aqueous and detergent-enriched phases was analyzed by western
66
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blots from cell lysates of MCF-10A cells and MDA-MB 435 human breast cancer 
cells. At 0 hours of exposure, all RhoA protein was located in the detergent- 
enriched phase following treatment with 0.5 mM perillyl alcohol in MCF-10A cells. 
However, after 18 hours of exposure RhoA protein accumulated in the aqueous 
phase in MCF-1OA cells. For MDA-MB 435 cells even at 0 hours of treatment 
(treatment for 30 minutes) with 0.3 mM perillyl alcohol RhoA accumulated in the 
aqueous phase, which was again detected after 18 hours of exposure. The 
morphological effects of perillyl alcohol were investigated in MCF-1 OA cells and 
MDA-MB 435 cells following an 18-hour exposure to 0.5 mM or 0.3 mM, 
respectively. Perillyl alcohol treated MCF-1 OA and MDA-MB 435 cells showed a 
complete disassembly of stress fiber and focal adhesion complex formation, 
consistent with a loss of RhoA protein function.
Introduction
Small G-proteins have been reported to play an important role in the 
metastatic behavior of tumor cells (1 ). Protein isoprenylation. a form of post- 
translational modification, allows these proteins to associate with the plasma 
membrane where they activate various targets for a wide range of biological 
activity—contractility, adhesion, cytokinesis, proliferation, neoplastic 
transformation and apoptosis (2). Therefore, blocking the activation of low 
molecular weight GTPases by inhibiting their isoprenylation could reduce 
metastasis (3). The monoterpene perillyl alcohol (POH) has been shown to block 
isoprenylation of RhoA, a small GTPase involved in a migration-signaling
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pathway, by competitively inhibiting the enzyme type I geranylgeranyl-protein 
transferase (4-5). However, the specifics of this inhibition vary among cell types 
and cellular environments (6). Perillyl alcohol’s mode of action in normal and 
malignant human breast cells is unknown. Thus, in determining the anticancer 
mechanism of perillyl alcohol, it is important to evaluate this biochemical effect in 
different cell types.
To understand how cell migration may be affected by perillyl alcohol 
treatment, it is necessary to identify proteins that are able to coordinate both cell 
shape and signaling pathways. A good candidate is the Rho family of proteins. 
These small GTPases are able to relay extracellular stimuli such as mitogen- 
activated-integrin-derived signals, as well as organize the actin cytoskeleton (7). 
Microinjection with activated and dominant negative Rho family members leads 
to a defined hierarchy of GTPase activation; activated Cdc42 activates Rad, 
which then activates RhoA (8-9). Rac appears to drive the development of 
lamellipodia, whereas Cdc42 stimulates the polymerization of actin at the front to 
the cell to form long, thin extensions called filopodia (8-9). RhoA activation leads 
to the production of large, highly organized focal adhesion complexes and actin 
stress fibers (8-9).
Activated RhoA binds to and activates the serine/threonine kinase Rho- 
kinase (ROKa) (8). This kinase is suggested to regulate cell contractility by 
indirectly increasing phosphorylation of myosin light chain through the inhibition 
of myosin phophatase activity (10) and by directly phosphorylating myosin light 
chain independently of myosin light chain kinase (11 ). Overall, through this
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pathway, RhoA activation results in bundling of actin filament into stress fibers 
and clustering of integrins into focal adhesions (Fig. 4.1). This membrane- 
cytoskeleton interaction has been reported to increase invasiveness in tumor 
cells from liver and breast tissue (12-13). Additionally, the level of RhoA 
expression has been reported to be several times higher in tumors than in 
surrounding normal tissue (12).
The objective of this study was to determine whether the isoprenylation of 
RhoA protein in perillyl alcohol treated breast cancer (MDA-MB 435) and 
nontumorigenic breast (MCF-1 OA) cells was altered. We hypothesized that the 
decreased migration observed in POH-treated MCF-1 OA and MDA-MB 435 cells 
would be the result of the translocation of RhoA to the cytosol, thus impairing its 
migration signaling pathway. By western blot, we found that the RhoA protein of 
exposed cells accumulated in the aqueous phase following lysing with a 
detergent buffer. This result suggests that RhoA isoprenylation in MCF-1 OA and 
MDA-MB 435 cells is affected by perillyl alcohol and that this may account for the 
observed decreased in MCF-1 OA migration previously reported. Furthermore, the 
morphological loss of actin stress fiber and focal adhesion formation following 
exposure of MCF-1 OA to perillyl alcohol indicates loss of RhoA function.
Materials and Methods 
Materials
MCF-1 OA and MDA-MB 435 cells were purchased from American Type 
Culture Collection. Epidermal growth factor, cholera toxin, insulin were obtained
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from Calbiochem (La Jolla, CA). Hydrocortisone was purchased from Sigma- 
Aldrich Chemicals (St. Louis, MO). Horse serum was purchased from Irvine 
Scientific (Santa Ana, CA). Perillyl alcohol was purchased from Aldrich Chemical 
Co. (Milwaukee, Wl). The MicroBCA kit was from Pierce (Rockford, IL). 
Immobilon-P transfer membrane is from Millipore (Bedford, MA). Mouse anti­
human RhoA IgG, mouse anti-human vinculin IgG and secondary goat anti­
mouse IgG-AP were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). CDP-star chemiluminescence reagent was purchased from Dupont-New 
England Nuclear (Boston, MA). Cell culture plates were purchased from VWR 
(Plainfield, NJ). Triton X-100 and X-114 were purchased from Sigma-Aldrich 
Chemicals (St. Louis, MO). Goat anti-mouse rhodamine-conjugated IgG , FITC- 
phalloidin and ELF-97 Immunohistochemical Mounting Medium were purchased 
from Molecular Probes (Eugene, OR).
Cell Culture
Cells were grown in 75 cm  ̂Falcon tissue-culture flasks and maintained at 
37° C and 5% CO2 in humidified chambers. MCF-1 OA cells were maintained in 
AM media—1:1 mixture of Ham’s F-12 medium and Dulbecco’s Modified Eagle’s 
Medium High Glucose with 2 mM L-glutamine from Irvine Scientific (Santa Ana, 
CA) supplemented with the following: epidermal growth factor (20 ng/ml), cholera 
toxin (100 ng/ml), insulin (0.01 mg/ml), hydrocortisone (500 ng/ml) and 5% horse 
serum. MDA-MB 435 cells were maintained in RPMI Medium 1640 
supplemented with 10% fetal bovine serum and 1% L-glutamine (29.2 mg/ml), 
penicillin G (10,000 units/ml) and streptomycin sulfate (10,000 ng/ml) from Irvine
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
71
Scientific (Santa Ana, CA). Cells were routinely passaged using trypsin/EDTA 
from Irvine Scientific (Santa Ana, CA).
Western Analvsis 
Subconfluent plates of MCF-1 OA and MDA-MB 435 cells treated with 
perillyl alcohol for 18 hours were washed in ice-cold PBS and lysed in ice-cold 
RIPA buffer and protein concentrations were determined by MicroBCA assay. 
Proteins were separated by 12% SDS-PAGE and transferred to Immobilon-P 
Transfer Membranes and processed for immunoblotting as previously described 
(15). Processed membranes incubated with primary antibody were then 
incubated with secondary goat anti-mouse IgG-AP and exposed to 
chemiluminescence reagent and developed on Kodak X-OMAT LS scientific 
imaging film.
Separating Proteins into Aqueous and Detergent-Enriched Phases 
The isoprenylated and unprocessed forms of RhoA proteins were 
separated into the detergent-enriched phase and the aqueous phase of 1 %
Triton X-114 TBS (20 mM Tris and 150 mM NaCI, pH 7.5) buffer as described by 
Guiterrez et al. (14). Perillyl alcohol (18 hr)-treated and untreated control cells 
were washed in ice-cold PBS and lysed with ice-cold 1% Triton X-114 TBS 
buffer. The cell debris was pelleted by centrifugation and the supernatant was 
incubated at 37° C for 5 minutes. The turbid solution was centrifuge^ at 16,000 g 
for 2 minutes, and the upper (aqueous) and the lower (detergent-enriched) 
phases were separated. By volume, equal percentages of RhoA proteins in the
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aqueous phase and the detergent-enriched phase were analyzed by SDS-PAGE 
and western blot as described above.
Immunohistochemistrv
Subconfluent MCF-1 OA and MDA-MB 435 cells plated on coverslips in 
serum-containing media for 24 hr were washed in PBS and treated with POH for 
18 hours. Cells were then washed in PBS, fixed in 4% paraformaldehyde, 
permeabilized with 0.3% Triton X-100 PBS, labeled with primary mouse anti- 
human vinculin antibody and double stained with secondary rhodamine- 
conjugated goat anti-mouse IgG antibody and FITC phalloidin after 30 minutes of 
incubation. Stained cells were analyzed with a Zeiss confocal microscope.
Results
To investigate whether perillyl alcohol decreases the isoprenylated RhoA 
levels by down-regulating protein production rather than through inhibiting type 1 
GGPTase, we measured RhoA levels in MCF-1 OA and MDA-MB 435 cells 
treated with perillyl alcohol by western bloL After 18 hours of treatment there 
was no difference in protein levels between treated and untreated cells (Fig. 4.2). 
There was a difference in RhoA protein expression between cell lines. The non­
tumorigenic MCF-1 OA cells express more RhoA protein compared to the MDA- 
MB 435 cancer cells as determined by equal protein loading.
Since perillyl alcohol inhibits type 1 GGPTase, we hypothesized that it 
would change the ratio of prenylated and unprenylated forms of RhoA protein.
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After separating proteins into aqueous (unprenylated) and detergent-enriched 
(prenylated) phases, proteins were detected by western blot. At 0 hours 
(treatment for 30 minutes) of exposure, all treatments with MCF-1 OA cells 
showed only the RhoA protein the detergent-enriched phase (Fig. 4.3). While at 
18 hours of exposure, there was an accumulation of RhoA protein in the aqueous 
phase in the treated MCF-1 OA cells as compared to the untreated (Fig. 4.4). 
Reciprocally, a decrease of RhoA protein in the detergent-enriched phase was 
seen in the treated versus untreated MCF-1 OA cells (Fig. 4.4). For MDA-MB 435 
cells at 0 hours of exposure, the aqueous phase contained RhoA protein when 
treated with perillyl alcohol, whereas in the same phase the untreated sample 
was void of the protein. At 18 hours of treatment. MDA-MB 435 cells continued 
to show an accumulation of RhoA protein in the aqueous phase for the perillyl 
alcohol treated cells as compared to the untreated cells (Fig. 4.5).
RhoA activated by serum growth factors can induce formation of stress 
fibers and focal adhesion complexes(16). As shown in figures 4.6 and 4.7. MCF- 
10A and MDA-MB 435 cells in the presence of serum-containing media had 
numerous stress fibers and focal adhesion complexes. When exposed to 
migration media alone for 18 hours, MCF-1 OA and MDA-MB 435 cells showed a 
slight decrease in the number of stress fibers and focal adhesion complexes (Fig. 
4.6 and 4.7). However, after 18 hours of treatment with perillyl alcohol in 
migration media, MCF-1 OA and MDA-MB 435 cells lost their stress fibers and 
the majority of their focal adhesion complexes (Fig. 4.6 and 4.7), resulting in the
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condensation of actin filaments and focal adhesion complex proteins within the 
center of the cells that is consistent with a loss of RhoA function.
Discussion
Our earlier work showed a decrease in cell migration for the 
nontumorigenic human breast cell line MCF-1 OA after exposure to 0.5 mM perillyl 
alcohol (POH). Previous studies suggest that perillyl alcohol inhibits protein 
isoprenylation in several malignant and non-malignant cell lines (5,17). Perillyl 
alcohol has been shown to inhibit the enzymes FPTase and types I and II 
GGPTase that catalyze the protein isoprenylation of small G-proteins (4). 
Inhibition of these three enzymes, however, has not been uniform; 
inconsistencies have been seen in the reduction of FPTase activity in different 
cell lines (4,18). Therefore, we looked for a possible link between the observed 
decrease in migration of MCF-1 OA cells and a change in activity of a small G- 
Protein. RhoA is a small GTPase that requires the addition of a 20-carbon 
isoprene group geranylgeranylpyrophosphate by the enzyme GGPTase for it to 
associate with the plasma membrane, where it takes place in migration signaling 
pathways (9).
Initially, to investigate the possibility that POH decreases the isoprenylated 
RhoA levels by down-regulating the protein rather than inhibiting type I 
GGPTase, we measured RhoA levels in POH-treated cells by western blot. Our 
results corroborate those of others that POH exposure does not change the
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levels of RhoA in comparison to those in control cells (4). We also found that the 
human breast cancer cell line MDA-MB 435 expresses less RhoA protein in 
comparison to MCF-1 OA cells. This was not what we anticipated because MDA- 
MB 435 is a highly invasive breast cancer cell line, and it has been shown that 
other types of tumor cells express several times the amount of RhoA protein 
compared to non-malignant cells (19). Additionally, cells overexpressing RhoA 
protein exhibit increased motility (12).
To confirm an effect of perillyl alcohol on RhoA protein isoprenylation in 
our two cell lines, we addressed the translocation of RhoA protein from the 
plasma membrane to the cytosol. The unprenylated form of RhoA protein cannot 
associate with the plasma membrane (20); therefore, upon exposure to perillyl 
alcohol RhoA accumulates in the cytosol. After an 18-hour treatment and with
0.5 mM POH. RhoA accumulated in the aqueous phase and, reciprocally, the 
detergent-enriched phase showed a decrease in RhoA protein in MCF-1 OA cells. 
At the 0-hour timepoint (treatment for 30 minutes), in the MCF-1 OA cell line no 
RhoA protein is detected in the aqueous phase for POH-treated or untreated 
cells. This may be due to the cells recruiting RhoA to the plasma membrane as 
they reorganize their cytoskeletons to form focal adhesion complexes and stress 
fibers for adhering to the fibronectin-coated plate.
Unlike the aforementioned observation in MCF-1 OA cells, a deposition of 
RhoA protein in the cytosolic phase was measured for the 0-hour timepoint 
(treatment for 30 minutes) following treatment with POH in the MDA-MB 435 
cells. After 18 hours of treatment with 0.3 mM POH, a small loss of RhoA protein
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from the detergent-phase was seen in the breast cancer cells. With MDA-MB 
435 cells expressing less RhoA protein, it is possible that the cells are more 
susceptible to the consequences of exposure to perillyl alcohol, even at 
subcytotoxic concentrations. Another scenario is that alternative pathways are 
being activated/inactivated by perillyl alcohol that lead to the increased ease by 
which RhoA is removed from the plasma membrane. It is likely that an apoptotic 
mechanism is at a low level of activation at this level of treatment; it has been 
reported that POH induces the expression of the proapoptotic protein Bak in 
pancreatic tumor cells, but does not in non-malignant pancreatic cells (21 ). It 
could also be that perillyl alcohol treatment is activating a different domain of an 
effector protein such as ROKa that leads to apoptosis in the MDA-MB 435 cells 
(22).
One effector protein of RhoA that is involved in a migration signaling 
pathway is ROKcx. The kinase activity of ROKa is essential for it to promote the 
formation of stress fibers and focal adhesion complexes (22). In both MCF-1 OA 
and MDA-MB 435 cell lines morphological changes occurred after treatment with 
perillyl alcohol. We observed a loss of stress fibers and focal adhesion 
complexes following an 18-hour exposure in both cell lines. This may be due to 
a loss of activated ROKa: a downstream target in the Rho-dependent pathway of 
stress fiber and focal adhesion complex formation (22).
The assembly and disassembly of focal adhesion complexes and 
concomitant cell spreading have been implicated in migration activities of tumor 
cells (23). Treatment of MCF-1OA cells with the monoterpene perillyl alcohol
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blocked their migration. One mechanism of action of POH is the inhibition of 
isoprenylation of such protein as small G-proteins. RhoA is a small GTPase 
involved in migration signaling pathway. Our investigation into an alteration of 
RhoA activity following POH treatment yielded positive results for both 
translocation of RhoA to the cytosol and loss of its effect on downstream 
cytoskeletal components: focal adhesion complex and stress fiber formation. 
Further examination into the mechanism of the diminished migration in POH- 
treated MCF-1 OA cells would be to measure the ability of ROKa to phosphorylate 
its substrates such as myosin light chain. However, the difference observed in 
the MDA-MB 435 cells following POH-treatment warrants investigation into the 
possibility of induced expression of pro-cell death proteins such as Bak. This 
would coincide with previous findings and advance the understanding of how 
perillyl alcohol affects normal tissues.
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Figure 4.1. An established pathway for RhoA activation coupled with stress fiber 
and focal adhesion formation that induces cell migration. LPA; lysophosphatidic 
acid. MBS; myosin-binding subunit of myosin phosphatase. MCL; myosin light 
chain.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
82
KDa B
148__
Figure 4.2. Following 18 hours of exposure to perillyl alcohol, RhoA protein 
levels in MCF-1 OA and MDA-MB 435 cells did not decrease, as measured by 
western blot. An equal amount of protein was loaded in each lane, as 
determined by a MicroBCA protein assay. A. MCF-1 OA with migration media. B. 
MCF-1 OA with migration media and 0.5 mM perillyl alcohol. C. MDA-MB 435 
with migration media. D. MDA-MB 435 with migration media and 0.3 mM perillyl 
alcohol.
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Figure 4.3. At 0 hours (treatment for 30 minutes) of exposure to 0.5 mM perillyl 
alcohol in MCF-1 OA cells, RhoA protein was found only in the detergent-enriched 
phase for all treatment conditions as measured by western blot An equal 
percentage of overall volume for each sample was loaded. A. AM media and 0.5 
mM perillyl alcohol. B. AM media. C. Migration media. D. Migration media and
0.5 mM perillyl alcohol.
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aqueous phase detergent phase
Figure 4.4. After an 18-hour incubation with 0.5 mM perillyl alcohol, RhoA 
protein in MCF-1 OA cells accumulated in the aqueous phase as determined by 
western blot. An equal percentage of overall volume was loaded for each 
sample. A. AM media. B. Migration media. C. Migration media and 0.5 mM 
perillyl alcohol.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
85
A B D C E A B C D
2 5 0 -
aqueous phase detergent phase
Figure 4.5. MDA-MB 435 cells showed an accumulation of RhoA protein in 
the aqueous phase after 0 (treatment for 30-minutes) and 18 hours of 
exposure to 0.3 mM perillyl alcohol as measured by western blot. An equal 
percentage of overall volume was loaded for each sample. A. Migration 
media, 0 hours. B. Migration media and 0.3 mM perillyl alcohol, 0 hours. C. 
Migration media, 18 hours. D. Migration media and 0.3 mM perillyl alcohol, 
18 hours. E. Whole cell lysate in migration media, 18 hours.
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Figure 4.6. After 18 hours, MCF-1 OA cells grown in AM media (A and D) show extensive actin stress fibers and 
numerous focal adhesion complexes throughout the cell body and at the cell periphery. Migration media (B and E) 
reduced the number of both focal adhesions and stress fibers while 0.5 mM perillyl alcohol (C and F) eliminated most. 
Cells were stained with phalloidin (A-C) and anti-vinculin antibody (D-F) for actin stress fibers and focal adhesion 
complexes, respectively. 00
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and numerous focal adhesion complexes throughout the cell body and at the cell periphery. Migration media (B and E) 
reduced stress fibers and focal adhesions while 0.3 mM perillyl alcohol (C and F) eliminated most. Cells were stained 
with phalloidin (A-C) and anti-vinculin antibody (D-F) for actin stress fibers and focal adhesion complexes, respectively. 00-.1
CHAPTER 5
GENERAL DISCUSSION 
The process of metastasis is both multi-faceted and progressive. Multiple 
aspects of cell physiology must be appreciated in order to gain a sense both of 
the opportunities for therapeutic intervention and the challenges of actually 
making clinical use of any new anti-metastatic therapies. Cell migration and 
invasion into the surrounding tissue are major characteristics of malignant 
tumors. Their migratory potential is a major obstacle to effective surgical 
therapy. The mechanism by which cancer cells migrate and consequently invade 
and extravasate, are not fully understood. Alterations in the expression of growth 
factor receptors (1), changes in the extracellular matrix-cell interactions (2) and 
signal transduction pathways (3) are likely to be of importance.
Drugs that interact with the locomotive apparatus of malignant cells are of 
great interest in cancer therapy. The discovery of drugs with anti-migratory 
properties has been hampered by the lack of adequate technology that can 
quickly and accurately measure cell migration. Our lab’s new 96-well migration 
plate, a tool for measuring cell migration and cell death, along with our migration 
assay can be used to screen for compounds that inhibit tumor cell migration (4). 
In this study, we define the conditions necessary for optimizing our high-
88
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throughput assay to screen anti-cancer compounds for their ability to stop tumor 
cell migration of established cell lines of the National Cancer Institute in vitro.
We determined that the concentration of dimethyl sulfoxide (DMSO) that 
induces cell death is greater than the concentration that interferes with cell 
migration of the four cell lines. Our interest in delineating these effects of DMSO 
is due to the likelihood that DMSO will be a solvent used in drug packaging by 
such institutions as the National Cancer Institute: a major repository for anti­
cancer compounds. Additionally, our results confirm that this assay protocol is 
capable of identifying non-cytotoxic, anti-migratory compounds (4). Importantly, 
we demonstrate that it is possible to separate the effect of DMSO from that of an 
anti-cancer drug for inhibiting cell migration.
Another parameter for optimization was selecting the preferred 
extracellular matrix (ECM) protein for migration in our four cell lines. Matrix 
proteins contribute to metastasis by stimulating tumor cell motility (5-9). Of these 
proteins we tested vitronectin, fibronectin, laminin and type IV collagen, finding 
that our four cell lines all maximally migrate on fibronectin; thus, simplifying the 
migration assay for a drug screen. These proteins stimulate chemotaxis (motility 
toward a chemical gradient) and haptotaxis (motility toward a bound substrate). 
The ability of ECM proteins to activate haptotaxis in tumor cells indicates that the 
intact ECM proteins may provide a path for the migration of tumor cells.
The relative number of cells needed to evenly cover the migration filter 
was determined. Ensuring that the seeded cells form a monolayer on the filter 
for the migration assay is necessary to mimic in vivo conditions. Of the four cell
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lines, the small cell lung carcinoma (NCI-H460) cells required approximately a 
third more cells than the other cell lines to form a monolayer.
Compilation of these parameters for optimizing our migration assay for a 
large-scale drug screen signifies that we are ready to proceed. It can reasonably 
be concluded that we are able to discern between the cytotoxicity of DMSO and 
its effect on cell migration in our assay. With the common use of DMSO as drug 
solvent, we should be able to apply our plate and assay to screen repositories of 
anti-cancer drugs such as that held by the National Cancer Institute.
To apply our optimized conditions for screening anti-cancer agents for 
anti-migration properties, we chose to investigate the monoterpenes limonene. 
perillyl alcohol and perillaldehyde. We found that these monoterpenes varied in 
cytotoxicity. The induced cell death of MCF-10A non-tumorigenic breast cells by 
perillaldehyde may be attributable to its increased affinity for the enzymes 
famesyl protein transferase (FPTase) and geranylgeranyl protein transferase 
(GGPTase) as compared to that of perillyl alcohol (POH) and limonene. Prior 
research has shown that the metabolite perillic acid of limonene and POH is 
much more effective in blocking FPTase and GGPTase (10). These enzymes 
are involved in post-translational modification of small G-proteins. which impact a 
plethora of cell activities such as growth, migration and apoptosis. The anti­
tumor effects of limonene and POH are suspected to be based on their inhibition 
of FPTase and GGPTase (10).
However, there is a disparity between equal concentrations of perillyl 
alcohol and limonene and their effects on cell proliferation (10-11 ). We found a
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decrease in POH-treated MCF-10A cell migration at non-cytotoxic levels. This 
was not attained for limonene. The most likely reason is that it is limonene 
metabolites, perillic acid and perillic acid methyl ester, that inhibit small G-protein 
isoprenylation effectively and not limonene (11-12).
A probable mediator of this inhibited migration is the small G-protein 
RhoA, a member of the Rho family of small GTPases that is involved in a cell 
migration signaling pathway (13-14). Interfering with the isoprenylation of RhoA 
would effectively block activation of Rho-kinase (ROKa), one of its downstream 
effector proteins (15). Overall this would deplete the cell of stress fibers and 
focal adhesion complexes—necessary components for contraction in cell 
migration (16).
Unlike migration, adhesion was much less affected by POH treatment in 
both MCF-10A and MDA-MB 435 cell lines. The requirements for adhering are 
less demanding on the cell than migrating. Turnover of focal adhesion 
complexes and remodeling of the plasma membrane are not required for 
adhesion. Thus, it is possible that after POH-treatment. the cells retain the 
capacity to bind to a fibronectin-coated surface, but not are not able to migrate 
through it.
To further assess POH as a possible inhibitor of cancer cell migration, we 
tested it in the human breast cancer cell line MDA-MB 435. Finding that POH 
could not inhibit migration without also being cytotoxic in this cell line was 
surprising. Previous research has shown that other tumor cell lines express 
more RhoA compared to non-tumorigenic cells (17). Additionally, an increased
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level of expression of RhoA has been associated with an invasive phenotype (17- 
18), and MDA-MB 435 is a highly motile cell line. However, our finding that POH 
is more cytotoxic in this cancer cell line compared to the non-tumorigenic one is 
supported by earlier research. Stayrook, et al. (19) found that POH significantly 
increased apoptosis in pancreatic cancer cells relative to non-malignant 
pancreas cells. Therefore, it is conceivable that POH is affecting a different 
mechanism in MDA-MB cells than in MCF-10A cells, which may be attributable to 
changes in RhoA function.
We initially investigated the effect of POH on RhoA by measuring the 
RhoA protein level in POH-treated cells to verify that its expression was not 
down-regulated. Our results suoport prior findings that RhoA protein expression 
is not altered by POH exposure (13). However, contrary to our assumptions, 
MDA-MB 435 cells express less RhoA than MCF-10A cells. Although, it has also 
been published that excessive RhoA activity in rat fibroblasts inhibits migration 
probably through the formation of strong focal adhesions (14).
To confirm an effect of perillyl alcohol on RhoA protein isoprenylation in 
our two cell lines, we addressed the translocation of RhoA protein from the 
plasma membrane to the cytosol. It is the isoprenylated form of RhoA that is 
capable of activating downstream targets such as Rho-kinase. Our finding with 
the MCF-10A cell line supports our hypothesis. After 18-hours of exposure, 
RhoA protein accumulates in the aqueous phase with a reciprocal depletion from 
the detergent-enriched phase. A difference was observed at the 0-hour 
(treatment for 30 minutes) timepoint; treated cells did not have a detectable
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amount of RhoA protein in the aqueous phase. After one hour of adhering to the 
plate surface, the cells were still not spread out, and therefore, RhoA may be 
recruited to the plasma membrane in an effort to reestablish stress fiber and focal 
adhesion complex formation.
In the MDA-MB 435 cell line translocation of RhoA to the aqueous phase 
was measured at the 0-hour timepoint although their appearance was similar to 
the MCF-10A cells. It may be that the lower expression of RhoA in this breast 
cancer cell line makes them more susceptible to the effects of perillyl alcohol 
treatment, even at a subcytotoxic dose. The increased sensitivity of the MDA- 
MB 435 cell line to POH suggests that it may experience more adverse effects 
with POH-treatment due to activation a pro-apoptosis pathway (20-21 ). Another 
study showed that expression of the pro-apoptotic protein Bak was induced by 
perillyl alcohol in pancreatic tumor cells, but was innocuous in non-malignant 
pancreas cells (19).
One target protein of activated RhoA is Rho-kinase. Phosphorylation of 
this serine/threonine kinase leads to the generation of stress fibers and focal 
adhesion complexes that provide the cell with contractile forces needed for 
migration (15). Following treatment with POH, we observed considerable 
morphological changes in both cell lines. Cells were round in appearance owing 
to their loss of stress fibers and focal adhesions; a possible manifestation due to 
the loss of Rho-kinase activity (15). From this point it is valid to advocate 
continued examination of the activity of Rho-kinase through more direct methods.
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Ideally, following perillyl alcohol treatment the activity of Rho-kinase should be 
measured through substrate phosphorylation.
It is known that the assembly and disassembly of focal adhesion 
complexes is integral to migration activities of tumor cells (22). Perillyl alcohol 
treatment in MCF-10A cells effectively inhibited their migration. Blocking the 
isoprenylation of small G-proteins is an established effect of perillyl alcohol. The 
small GTPase RhoA is involved in a migration signaling pathway. We were able 
to show that following POH-treatment RhoA accumulated in the aqueous phase 
and that morphological changes occurred. These cells lost stress fibers and 
focal adhesion complexes indicative of a loss of RhoA function. However, what 
remains to be clarified is why this loss of isoprenylated proteins impacts different 
cell types in diverse ways as seen in our study with non-tumorigenic breast cells 
and malignant breast cells. Perhaps the intracellular level of the geranylgeranyl 
diphosphate, the substrate for GGPTase, is much lower in contrast to the much 
higher intracellular farneslyl diphosphate concentration (23) and with further 
variation depending on the cell type (13). If this is true, then perillyl alcohol could 
effectively compete with the endogenous substrate for GGPTase I but not 
FPTase. Oncogenic Ras proteins are present in 30% of all human cancers, and 
normal and oncogenic Ras are substrates for isoprenylation by FPTase (24). 
This may partially explain the observed difference between our non-malignant 
breast cells and breast cancer cells following perillyl alcohol treatment.
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